Earnings are out
Scribe Therapeutics (SCTX)
Develops CasX-based genetic medicines for lipid-linked cardiometabolic disease.
$31.00
Pre-market+0.19 (+0.62%)
At close$30.81(+6.24%)
Something off on this page? Send us feedback.
EPSReportedEstimate
———————Sep '26
Reported———————−$2.62
Estimate———————−$3.62
Surprise———————+27.6%
RevenueReportedEstimate
———————Sep '26
Reported———————$1.9M
Estimate———————$3.1M
Surprise———————−38.6%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$3.62 | −$2.62 | +27.6% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | −$3.62 | −$2.62 | +27.6% | $3.1M | $1.9M | −38.6% | — |